# A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic

> **NCT02434822** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 336 (actual)

## Conditions studied

- Cholera

## Interventions

- **BIOLOGICAL:** Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
- **BIOLOGICAL:** Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
- **BIOLOGICAL:** Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

## Key facts

- **NCT ID:** NCT02434822
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-09
- **Final completion:** 2016-07
- **Target enrollment:** 336 (ACTUAL)
- **Last updated:** 2018-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02434822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02434822, "A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02434822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*